Grant awarded to help bring to market an innovative treatment for bone cancer
A grant has been awarded to look into the feasibility of bringing to market a…
September 23, 2022 - 3 minutes
News and Trends
Beyond Biotech podcast 15: Cullinan Oncology, Pleco Therapeutics, TikoMed
This week’s podcast has three guests. In honor of World Cancer Research Day on September…
September 23, 2022 - 4 minutes
News and Trends
Research identifies new treatment target for CNS injury and neurological disease
Researchers in Birmingham in the U.K. have identified a potential target for drugs to treat…
September 22, 2022 - 3 minutes
News and Trends
Promising MND drug slows disease progression
Scientists in the U.K. believe a new genetically-targeted therapy to treat motor neurone disease (MND)…
September 22, 2022 - 4 minutes
What's New
MoreKnockback for drug to treat patients with relapsed or refractory multiple myeloma
A Swedish biotech company says it believes its treatment could be the ‘canary in the…
September 23, 2022 - 3 minutes
Study data for glioblastoma treatment confirms safety and tolerability profile
The final results of a phase 1/2 study of a therapy in recurrent glioblastoma multiforme…
September 22, 2022 - 4 minutes
Rivus Pharmaceuticals raises $132M for treatment of obesity and cardio-metabolic disorders
Rivus Pharmaceuticals Inc. has completed a $132 million series B financing round. It was led…
September 22, 2022 - 3 minutes
Emyria starts program with neuroscience drug discovery CRO
Emyria Limited, a clinical stage biotech, is set to work with PsychoGenics, a specialist neuroscience…
September 22, 2022 - 2 minutes
Cartography Biosciences unearths cancer immunotherapy targets
Despite its meteoric growth in the last twenty years, cancer immunotherapy research is hamstrung by…
September 22, 2022 - 5 minutes
New phase 1 biomarker results reported by Glyscend Therapeutics for diabetes drug
A U.S.-based biotech yesterday (September 21) reported additional biomarker results for a treatment of type…
September 22, 2022 - 4 minutes
National Hemophilia Foundation launches research fund
The National Hemophilia Foundation (NHF) in the U.S. has announced the launch of Pathway to…
September 22, 2022 - 4 minutes
Swiss scientists reduce resistance of dormant melanoma cells
Small-molecule targeted therapies revolutionized the treatment of metastatic melanoma, provided that the tumors carry the…
September 22, 2022 - 4 minutes
From Our Partners
View More
Sponsored
by ACROBiosystems
How high quality raw materials help cell therapies successfully translate from bench to bedside
Sponsored
by LINK Medical
How clinical trials benefit from decentralized solutions: A Nordic case study
Sponsored
by Computomics
Metagenomics: unlocking the secrets of microbial communities
Sponsored
by Kadans Science Partner
How open ecosystems encourage knowledge sharing and accelerate scientific innovation
Download our industry reports
View all our reports
